The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.
September 1, 2011|
Editor’s Choice in Immunology
April 1, 2011|
Are miRNAs useful for tracking and treating cardiovascular disease?
February 1, 2011|
Fast blood flow protects against atherosclerosis: implications for treatment